Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells

Journal of Virology

Volumn 75, Issue 24, 2001, Pages 12128-12140

  Bukreyev, A ^a   Belyakov, I M ^a   Berzofsky, J A ^a   Murphy, B R ^a   Collins, P L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P40; RRSV MGMCSF; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LOWER RESPIRATORY TRACT INFECTION; LYMPHOID CELL; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRUS REPLICATION;

EID: 0035198506     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.24.12128-12140.2001     Document Type: Article

References (37)

1. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: Granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
2. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV
3. Analysis of the local and systemic immune responses induced in Balb/c mice by experimental respiratory syncytial virus infection
4. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse
5. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL
6. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
7. Activating CTL precursors to reveal the CTL repertoire without skewing caused by in vitro stimulation
8. The M2-2. Protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
9. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene
10. Respiratory syncytial virus can tolerate an intergenic sequence of at least 160 nucleotides with little effect on transcription or replication in vitro and in vivo
11. Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity
12. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines
13. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test
14. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
15. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus
16. Respiratory syncytial virus
17. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
18. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10
19. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees
20. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
21. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity
22. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus
23. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection
24. Thl and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus
25. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
26. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
27. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus
28. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3 to 6 months after immunization
29. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
30. Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma
31. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response
32. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection
33. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs
34. Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung
35. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV
36. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
37. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines